Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Formycon AG

Start price
Target price
Perf. (%)
€65.20
12.12.20
-
12.12.21
-7.06%
11.03.21

Could be worthwhile Investment >10% per year
buy
Bayer AG

Start price
Target price
Perf. (%)
€46.63
12.12.20
-
12.12.21
17.84%
16.02.21

Higher risks for its business
Increased challenges to pay loans and raise capital
buy
Evotec SE

Start price
Target price
Perf. (%)
€25.50
29.11.20
-
29.11.21
20.04%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€3.38
26.11.20
-
16.11.21
198.22%
17.11.21

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.20
22.11.20
€73.00
22.11.21
-0.41%
23.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Very high dividend yield expected
buy
MagForce AG

Start price
Target price
Perf. (%)
€3.01
18.11.20
€4.00
18.11.21
12.29%
19.11.21

Could be worthwhile Investment >10% per year
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€36.97
12.11.20
€50.00
12.11.21
21.49%
13.07.21

Top 10 in its market
Small cyclical dependencies
Below average Management
buy
Evotec SE

Start price
Target price
Perf. (%)
€24.26
09.11.20
-
09.11.21
21.35%
14.01.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€34.41
09.11.20
€40.00
09.11.21
18.27%
02.11.21

Could be very worthwhile Investment >20% year
Market Leader or Top 3
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Bio-Gate AG

Start price
Target price
Perf. (%)
€5.90
04.11.20
-
04.11.21
-32.20%
05.11.21

Growths faster than the competition
Few uniques
Dependend from some customers or products
Probably not worthwhile Investment
buy
Bayer AG

Start price
Target price
Perf. (%)
€42.35
23.10.20
€54.00
04.11.21
17.72%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Evotec SE

Start price
Target price
Perf. (%)
€23.57
19.10.20
-
04.11.21
25.20%
11.03.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
buy
Epigenomics AG NA

Start price
Target price
Perf. (%)
€0.51
18.10.20
€1.00
02.11.20
20.00%
02.11.20

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Innovative
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.90
18.10.20
€50.00
04.11.21
6.54%
12.10.21

Could be worthwhile Investment >10% per year
buy
Paion AG

Start price
Target price
Perf. (%)
€2.55
17.10.20
€5.00
04.11.21
-27.69%
05.11.21

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.51
15.10.20
€5.00
19.10.20
0.28%
19.10.20

Could be worthwhile Investment >10% per year
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.22
14.10.20
€47.00
04.11.21
8.47%
11.11.20

Undervalued
Risky Investment
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.89
13.10.20
-
04.11.21
14.74%
21.06.21

Merck KGaA

Start price
Target price
Perf. (%)
€124.80
23.09.20
-
04.11.21
4.17%
25.11.20

ROE higher than 10% per year
Low dividend yield expected
buy
Evotec SE

Start price
Target price
Perf. (%)
€23.43
23.09.20
€36.00
04.11.21
58.26%
21.06.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Fair valuation
High Investments for future growth
buy
Medigene AG

Start price
Target price
Perf. (%)
€4.63
16.09.20
€6.00
21.09.20
-4.54%
21.09.20

Could be worthwhile Investment >10% per year
buy
Stratec SE

Start price
Target price
Perf. (%)
€103.60
29.08.20
€120.00
31.08.20
-3.09%
31.08.20

Risky Investment
Stratec SE

Start price
Target price
Perf. (%)
€105.60
28.08.20
€95.00
04.11.21
5.30%
17.06.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
High valuation
Very low/no dividend yield expected
buy
Bayer AG

Start price
Target price
Perf. (%)
€57.13
19.08.20
€70.00
04.11.21
-19.84%
10.11.20

Could be worthwhile Investment >10% per year
Innovative
Very Future proof/growth oriented business model
Known brand
buy
CytoTools AG

Start price
Target price
Perf. (%)
€10.20
12.08.20
€26.00
04.11.21
56.86%
13.04.21

Could be very worthwhile Investment >20% year
Differentiated customer and product portfolio